Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Hendriks

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Clinical Genetics|April 13, 2017
Two novel MYLK nonsense mutations causing thoracic aortic aneurysms/dissections in patients without apparent family historyI Luyckx, D Proost, J M H Hendriks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2008
Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancerBart P van Putte, Marco Grootenboers, Wim-Jan van Boven, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2024
Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunctionAxelle Coppens, Stijn E Verleden, Erik Claes, et al.
Antioxidants (Basel, Switzerland)|November 27, 2025
Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand?Lawek Berzenji, Jeroen M H Hendriks, Stijn E Verleden, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 19, 2010
Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastasesWillem A Den Hengst, Bart P Van Putte, Jeroen M H Hendriks, et al.
Cancers|May 16, 2023
Innovative Invasive Loco-Regional Techniques for the Treatment of Lung CancerErik Claes, Reinier Wener, Arne P Neyrinck, et al.
The European Respiratory Journal|February 29, 2024
Interalveolar pore morphology in (pre-)COPD stages and associations with small airwaysStijn E Verleden, Therese S Lapperre, Annemiek Snoeckx, et al.
JACC. Cardiovascular Interventions|December 13, 2023
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal LesionsKoen R Deloose, Wouter Lansink, Marianne Brodmann, et al.
Journal of Surgical Oncology|November 14, 2007
Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trialMarco Jj H Grootenboers, Jeroen M H Hendriks, Wim J van Boven, et al.
Cancers|September 9, 2022
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care TherapyChristophe Deben, Maxim Le Compte, Vasiliki Siozopoulou, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Clinical Genetics|April 13, 2017
Two novel MYLK nonsense mutations causing thoracic aortic aneurysms/dissections in patients without apparent family historyI Luyckx, D Proost, J M H Hendriks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2008
Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancerBart P van Putte, Marco Grootenboers, Wim-Jan van Boven, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2024
Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunctionAxelle Coppens, Stijn E Verleden, Erik Claes, et al.
Antioxidants (Basel, Switzerland)|November 27, 2025
Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand?Lawek Berzenji, Jeroen M H Hendriks, Stijn E Verleden, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 19, 2010
Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastasesWillem A Den Hengst, Bart P Van Putte, Jeroen M H Hendriks, et al.
Cancers|May 16, 2023
Innovative Invasive Loco-Regional Techniques for the Treatment of Lung CancerErik Claes, Reinier Wener, Arne P Neyrinck, et al.
The European Respiratory Journal|February 29, 2024
Interalveolar pore morphology in (pre-)COPD stages and associations with small airwaysStijn E Verleden, Therese S Lapperre, Annemiek Snoeckx, et al.
JACC. Cardiovascular Interventions|December 13, 2023
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal LesionsKoen R Deloose, Wouter Lansink, Marianne Brodmann, et al.
Journal of Surgical Oncology|November 14, 2007
Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trialMarco Jj H Grootenboers, Jeroen M H Hendriks, Wim J van Boven, et al.
Cancers|September 9, 2022
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care TherapyChristophe Deben, Maxim Le Compte, Vasiliki Siozopoulou, et al.
Pageof 10